MediWound Ltd. M8W.F Stock
MediWound Ltd. Price Chart
MediWound Ltd. M8W.F Financial and Trading Overview
| MediWound Ltd. stock price | 14.8 EUR |
| Previous Close | 8.7 EUR |
| Open | 8.7 EUR |
| Bid | 8.7 EUR x 70000 |
| Ask | 9.35 EUR x 60000 |
| Day's Range | 8.7 - 8.7 EUR |
| 52 Week Range | 7.77 - 14.84 EUR |
| Volume | 75 EUR |
| Avg. Volume | 13 EUR |
| Market Cap | 85.29M EUR |
| Beta (5Y Monthly) | 1.042605 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.69 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.92 EUR |
M8W.F Valuation Measures
| Enterprise Value | 16.93M EUR |
| Trailing P/E | N/A |
| Forward P/E | -17.4 |
| PEG Ratio (5 yr expected) | -0.08 |
| Price/Sales (ttm) | 3.2947586 |
| Price/Book (mrq) | 2.1914358 |
| Enterprise Value/Revenue | 0.654 |
| Enterprise Value/EBITDA | -2.166 |
Trading Information
MediWound Ltd. Stock Price History
| Beta (5Y Monthly) | 1.042605 |
| 52-Week Change | 2.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.84 EUR |
| 52 Week Low | 7.77 EUR |
| 50-Day Moving Average | 9.9 EUR |
| 200-Day Moving Average | 10.51 EUR |
M8W.F Share Statistics
| Avg. Volume (3 month) | 13 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 9.47M |
| Float | 6.05M |
| Short Ratio | N/A |
| % Held by Insiders | 24.23% |
| % Held by Institutions | 26.30% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -76.10% |
| Operating Margin (ttm) | -32.97% |
| Gross Margin | 48.40% |
| EBITDA Margin | -30.20% |
Management Effectiveness
| Return on Assets (ttm) | -11.22% |
| Return on Equity (ttm) | -111.80% |
Income Statement
| Revenue (ttm) | 25.89M EUR |
| Revenue Per Share (ttm) | 4.27 EUR |
| Quarterly Revenue Growth (yoy) | -13.80% |
| Gross Profit (ttm) | 13.17M EUR |
| EBITDA | -7819000 EUR |
| Net Income Avi to Common (ttm) | -19703000 EUR |
| Diluted EPS (ttm) | -3.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 57.2M EUR |
| Total Cash Per Share (mrq) | 6.82 EUR |
| Total Debt (mrq) | 743K EUR |
| Total Debt/Equity (mrq) | 2.23 EUR |
| Current Ratio (mrq) | 6.83 |
| Book Value Per Share (mrq) | 3.97 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7168000 EUR |
| Levered Free Cash Flow (ttm) | -6509000 EUR |
Profile of MediWound Ltd.
| Country | Germany |
| State | N/A |
| City | Yavne |
| Address | 42 Hayarkon Street |
| ZIP | 8122745 |
| Phone | 972 7 797 14100 |
| Website | https://www.mediwound.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 83 |
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Q&A For MediWound Ltd. Stock
What is a current M8W.F stock price?
MediWound Ltd. M8W.F stock price today per share is 14.8 EUR.
How to purchase MediWound Ltd. stock?
You can buy M8W.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MediWound Ltd.?
The stock symbol or ticker of MediWound Ltd. is M8W.F.
Which industry does the MediWound Ltd. company belong to?
The MediWound Ltd. industry is Biotechnology.
How many shares does MediWound Ltd. have in circulation?
The max supply of MediWound Ltd. shares is 9.63M.
What is MediWound Ltd. Price to Earnings Ratio (PE Ratio)?
MediWound Ltd. PE Ratio is now.
What was MediWound Ltd. earnings per share over the trailing 12 months (TTM)?
MediWound Ltd. EPS is -0.69 EUR over the trailing 12 months.
Which sector does the MediWound Ltd. company belong to?
The MediWound Ltd. sector is Healthcare.